| Swapna A Eisinger, MD | |
|
5255 E Stop 11 Rd Ste 400, Indianapolis, IN 46237-6341 | |
| (317) 844-7059 | |
| (317) 819-0044 |
| Full Name | Swapna A Eisinger |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 13 Years |
| Location | 5255 E Stop 11 Rd Ste 400, Indianapolis, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952689085 | NPI | - | NPPES |
| 300005515 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 01078079A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Franciscan Health Indianapolis | Indianapolis, IN | Hospital |
| Community Hospital South, Inc. | Indianapolis, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Physicians Of Indiana Inc | 1759416662 | 1319 |
| Otolaryngology Associates Llc | 7810931409 | 50 |
News Archive
There's no telling where the call will come from, or when. But Randy Cron, M.D., Ph.D., professor of pediatrics and medicine at UAB, knows to expect them.
According to a new study, African American men with clinical chronic prostatitis have a significantly lower risk of prostate cancer.
The dynamics of evolution are fully in play within the environment of a tumor, just as they are in forests and meadows, oceans and streams.
Each year, kidney cancer is diagnosed in nearly 60,000 people in the U.S. Many of these patients undergo surgery to remove the affected kidney, but this procedure can be risky for the elderly and those who have other health problems. Unfortunately, the prognosis of kidney cancer patients often cannot be determined until tumor samples are surgically removed and evaluated.
pSivida Corp., a specialty pharmaceutical company that is a leader in developing sustained release drugs for treatment of back-of-the-eye diseases, today announced that its licensee Alimera Sciences, Inc. has received a Complete Response Letter for the New Drug Application for ILUVIEN from the U.S. Food and Drug Administration.
› Verified 9 days ago
| Entity Name | Otolaryngology Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447398839 PECOS PAC ID: 7810931409 Enrollment ID: O20050614001395 |
News Archive
There's no telling where the call will come from, or when. But Randy Cron, M.D., Ph.D., professor of pediatrics and medicine at UAB, knows to expect them.
According to a new study, African American men with clinical chronic prostatitis have a significantly lower risk of prostate cancer.
The dynamics of evolution are fully in play within the environment of a tumor, just as they are in forests and meadows, oceans and streams.
Each year, kidney cancer is diagnosed in nearly 60,000 people in the U.S. Many of these patients undergo surgery to remove the affected kidney, but this procedure can be risky for the elderly and those who have other health problems. Unfortunately, the prognosis of kidney cancer patients often cannot be determined until tumor samples are surgically removed and evaluated.
pSivida Corp., a specialty pharmaceutical company that is a leader in developing sustained release drugs for treatment of back-of-the-eye diseases, today announced that its licensee Alimera Sciences, Inc. has received a Complete Response Letter for the New Drug Application for ILUVIEN from the U.S. Food and Drug Administration.
› Verified 9 days ago
| Entity Name | Community Physicians Of Indiana Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619105244 PECOS PAC ID: 1759416662 Enrollment ID: O20100317000717 |
News Archive
There's no telling where the call will come from, or when. But Randy Cron, M.D., Ph.D., professor of pediatrics and medicine at UAB, knows to expect them.
According to a new study, African American men with clinical chronic prostatitis have a significantly lower risk of prostate cancer.
The dynamics of evolution are fully in play within the environment of a tumor, just as they are in forests and meadows, oceans and streams.
Each year, kidney cancer is diagnosed in nearly 60,000 people in the U.S. Many of these patients undergo surgery to remove the affected kidney, but this procedure can be risky for the elderly and those who have other health problems. Unfortunately, the prognosis of kidney cancer patients often cannot be determined until tumor samples are surgically removed and evaluated.
pSivida Corp., a specialty pharmaceutical company that is a leader in developing sustained release drugs for treatment of back-of-the-eye diseases, today announced that its licensee Alimera Sciences, Inc. has received a Complete Response Letter for the New Drug Application for ILUVIEN from the U.S. Food and Drug Administration.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Swapna A Eisinger, MD 9002 N Meridian St Ste 222, Indianapolis, IN 46260-5350 Ph: (317) 844-7059 | Swapna A Eisinger, MD 5255 E Stop 11 Rd Ste 400, Indianapolis, IN 46237-6341 Ph: (317) 844-7059 |
News Archive
There's no telling where the call will come from, or when. But Randy Cron, M.D., Ph.D., professor of pediatrics and medicine at UAB, knows to expect them.
According to a new study, African American men with clinical chronic prostatitis have a significantly lower risk of prostate cancer.
The dynamics of evolution are fully in play within the environment of a tumor, just as they are in forests and meadows, oceans and streams.
Each year, kidney cancer is diagnosed in nearly 60,000 people in the U.S. Many of these patients undergo surgery to remove the affected kidney, but this procedure can be risky for the elderly and those who have other health problems. Unfortunately, the prognosis of kidney cancer patients often cannot be determined until tumor samples are surgically removed and evaluated.
pSivida Corp., a specialty pharmaceutical company that is a leader in developing sustained release drugs for treatment of back-of-the-eye diseases, today announced that its licensee Alimera Sciences, Inc. has received a Complete Response Letter for the New Drug Application for ILUVIEN from the U.S. Food and Drug Administration.
› Verified 9 days ago
Dr. Bruce H. Matt, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 705 Riley Hospital Dr, Suite 0860, Indianapolis, IN 46202 Phone: 317-944-8620 Fax: 317-944-8080 | |
Dr. Jason J Gutt, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5255 E Stop 11 Rd, Suite 400, Indianapolis, IN 46237 Phone: 317-573-4370 Fax: 317-819-0044 | |
Jessica A. Yesensky, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 550 University Blvd Ste 3170, Indianapolis, IN 46202 Phone: 317-948-3226 | |
William R Nunery, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 201 Pennsylvania Pkwy, Suite 225, Indianapolis, IN 46280 Phone: 317-573-1000 Fax: 317-573-0205 | |
Dr. Babar Sultan, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 170 W 106th St, Meridian Plastic Surgery, Indianapolis, IN 46290 Phone: 317-575-0330 | |
Dr. Eric Y Knoll, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5255 E Stop 11 Rd, Suite 400, Indianapolis, IN 46237 Phone: 317-844-7059 Fax: 317-819-0044 | |
Dr. Benjamin J Copeland, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5255 E Stop 11 Rd Ste 400, Indianapolis, IN 46237 Phone: 317-844-7059 Fax: 317-819-0044 |